PULMATRIX, INC. Goodwill
PULMATRIX, INC. (PULM) had Goodwill of $3.58 million as of 2021-06-30, per its 10-Q filed 2021-08-10.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:Goodwill · last filed 2022-03-29
- 2021-06-30: Goodwill $3.58M.
- 2021-03-31: Goodwill $3.58M.
- 2020-12-31: Goodwill $3.58M.
- 2020-09-30: Goodwill $3.58M.
| Period end | Goodwill | Goodwill as first filed |
|---|---|---|
| 2021-06-30 | $3.58M 10-Q · filed 2021-08-10 | |
| 2021-03-31 | $3.58M 10-Q · filed 2021-05-11 | |
| 2020-12-31 | $3.58M 10-K · filed 2022-03-29 | |
| 2020-09-30 | $3.58M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $3.58M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $3.58M 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $3.58M 10-K · filed 2021-03-23 | |
| 2019-09-30 | $3.58M 10-Q · filed 2019-11-01 | |
| 2019-06-30 | $3.58M 10-Q · filed 2019-08-05 | |
| 2019-03-31 | $10.05M 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $10.85M 10-K · filed 2020-03-26 | |
| 2018-09-30 | $10.91M 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $10.91M 10-Q · filed 2018-08-03 | |
| 2018-03-31 | $10.91M 10-Q · filed 2018-05-11 | |
| 2017-12-31 | $10.91M 10-K · filed 2019-02-19 | |
| 2017-09-30 | $10.91M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $10.91M 10-Q · filed 2017-08-04 | |
| 2017-03-31 | $10.91M 10-Q · filed 2017-05-05 | |
| 2016-12-31 | $10.91M 10-K · filed 2018-03-13 | |
| 2016-09-30 | $15.94M 10-Q · filed 2016-11-04 | |
| 2016-06-30 | $15.94M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $15.94M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $15.94M 10-K · filed 2018-03-13 | $15.94M 10-K · filed 2016-03-10 |
| 2015-09-30 | $15.94M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $15.94M 10-Q · filed 2015-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |